Same here. I see Sirtex as a company with an excellent and profitable track record.
A successful trial result would have paved way for a newer product (ergo, increase in stock price based on new valuation). The failed test result should only result in a devaluation that subtracts money paid for the clinical trials. I concede that there was some amount invested into the company in anticipation of successful trial result. However, I believe that the current devaluation does not correctly reflect the underlying value of Sirtex, which has been doing just fine for a long time.
- Forums
- ASX - By Stock
- SRX
- Clinical Trial Objectives
Clinical Trial Objectives, page-39
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SRX (ASX) to my watchlist
|
|||||
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $74.27M |
Open | High | Low | Value | Volume |
17.5¢ | 17.5¢ | 17.5¢ | $40.84K | 233.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 3931600 | 17.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.0¢ | 2216405 | 37 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 3931600 | 0.175 |
6 | 1607688 | 0.170 |
1 | 18186 | 0.165 |
1 | 11500 | 0.155 |
1 | 2577 | 0.097 |
Price($) | Vol. | No. |
---|---|---|
0.180 | 2216405 | 37 |
0.185 | 107277 | 7 |
0.190 | 208390 | 11 |
0.195 | 520478 | 3 |
0.200 | 550275 | 11 |
Last trade - 13.44pm 19/08/2024 (20 minute delay) ? |
Featured News
SRX (ASX) Chart |